Literature DB >> 12694579

HLA in coeliac disease: unravelling the complex genetics of a complex disorder.

A S Louka1, L M Sollid.   

Abstract

Coeliac disease (gluten sensitive enteropathy) is a common, polygenic and multifactorial disorder that serves as a pioneering model for the study of inflammatory disease. A major environmental factor is known (ingested gluten from wheat), and there is unprecedented genetic and functional evidence pinpointing HLA-DQA1*05-DQB1*02 ( DQ2) and DQA1*03-DQB1*0302 ( DQ8) in disease predisposition. We discuss the current state of play in coeliac disease genetics, focussing particularly on the HLA complex. Emerging evidence suggests that additional HLA risk loci exert weak effects, independent of DQA1*05-DQB1*02, on the B8-DR3-DQ2 haplotype. There is also good evidence from linkage studies of disease gene(s) on chromosome 5q. We discuss the role and implications of linkage disequilibrium and haplotype blocks in complex disease gene mapping. We briefly address findings from studies of animal models for chronic inflammatory disease, and consider roles for both common genes associated with multiple inflammatory diseases, and genes unique to coeliac disease. The coeliac genetics research community has established a sound foundation for the identification of additional disease genes in the not-too-distant future. Functional studies will play a critical role, and coeliac disease has a promising future in this respect. Coeliac disease continues to function as a model disorder, facilitating the development and implementation of complex disease gene mapping strategies.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12694579     DOI: 10.1034/j.1399-0039.2003.00017.x

Source DB:  PubMed          Journal:  Tissue Antigens        ISSN: 0001-2815


  39 in total

Review 1.  Intraepithelial lymphocytes in celiac disease immunopathology.

Authors:  Valérie Abadie; Valentina Discepolo; Bana Jabri
Journal:  Semin Immunopathol       Date:  2012-06-03       Impact factor: 9.623

Review 2.  Regulation of intestinal epithelial permeability by tight junctions.

Authors:  Takuya Suzuki
Journal:  Cell Mol Life Sci       Date:  2012-07-11       Impact factor: 9.261

Review 3.  Celiac disease: pathogenesis of a model immunogenetic disease.

Authors:  Martin F Kagnoff
Journal:  J Clin Invest       Date:  2007-01       Impact factor: 14.808

Review 4.  New aspects in celiac disease.

Authors:  M I Torres; M A López Casado; A Ríos
Journal:  World J Gastroenterol       Date:  2007-02-28       Impact factor: 5.742

Review 5.  Translational mini-review series on the immunogenetics of gut disease: immunogenetics of coeliac disease.

Authors:  P C Dubois; D A van Heel
Journal:  Clin Exp Immunol       Date:  2008-08       Impact factor: 4.330

6.  Predictors of family risk for celiac disease: a population-based study.

Authors:  Alberto Rubio-Tapia; Carol T Van Dyke; Brian D Lahr; Alan R Zinsmeister; Mounif El-Youssef; S Breanndan Moore; Martha Bowman; Lawrence J Burgart; L Joseph Melton; Joseph A Murray
Journal:  Clin Gastroenterol Hepatol       Date:  2008-06-30       Impact factor: 11.382

Review 7.  Tissue-mediated control of immunopathology in coeliac disease.

Authors:  Bana Jabri; Ludvig M Sollid
Journal:  Nat Rev Immunol       Date:  2009-12       Impact factor: 53.106

8.  Increased risk for non-Hodgkin lymphoma in individuals with celiac disease and a potential familial association.

Authors:  Ying Gao; Sigurdur Y Kristinsson; Lynn R Goldin; Magnus Björkholm; Neil E Caporaso; Ola Landgren
Journal:  Gastroenterology       Date:  2008-09-25       Impact factor: 22.682

Review 9.  Involvement of interleukin-15 and interleukin-21, two gamma-chain-related cytokines, in celiac disease.

Authors:  Daniela De Nitto; Ivan Monteleone; Eleonora Franzè; Francesco Pallone; Giovanni Monteleone
Journal:  World J Gastroenterol       Date:  2009-10-07       Impact factor: 5.742

10.  Aberrant extrathymic T cell receptor gene rearrangement in the small intestinal mucosa: a risk factor for coeliac disease?

Authors:  A Bas; G Forsberg; V Sjöberg; S Hammarström; O Hernell; M-L Hammarström
Journal:  Gut       Date:  2008-02-25       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.